NMD Pharma to advance neuromuscular disorder therapies with €38m Series A round
Company Presentation
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Initiator Pharma
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile
Initiator Pharma
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
AU 2016/279486 A1 - Compounds For Use In Treating Neuromuscular Disorders - The Lens - Free & Open Patent and Scholarly Search
Initiator Pharma
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
NMD Pharma A/S | LinkedIn
PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO SHAREHOLDERS IN SANIONA AB
Annual Report 2016 by Lundbeckfonden - issuu
BioLeader Interview - PIR International
Claus Elsborg Olesen - Biography
UNIVERSITY OF COPENHAGEN Project title Novel Treatments of Neuromuscular Disease Mentor 1 Pontus Gourdon, MSc & PhD,
Initiator udsteder aktier og warrants for at finansiere fase 2-forsøg
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Initiator Pharma
Company Presentation
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
NMD Pharma
Prominent Canadian researcher in Denmark: Why I left a top job in California
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile
